The Osredkar’s group has recently reported that when assessed in combination with PIGF or with the sFlt-1/PIGF ratio, inhibin-A markedly and significantly increased the detection rate of pre-eclampsia and pre-eclampsia complicated by fetal growth restriction in most of the cases, the only limitation being cases of fetal growth restriction in deliveries earlier than 34 weeks, wherefore the diagnostic predictive value of inhibin-A was rather limited [43]. This evidence concerns the gene PIGF and fetal growth restriction.